Our team brings more than 200 years of combined professional experience in healthcare innovation.
Clinical Advisory Board & Collaborators
In 2004, Dr. Maher joined the Division of Pediatric Cardiology at Children’s Healthcare of Atlanta and Emory University. He currently serves on the Cardiac Executive Leadership Committee to help direct the current and future activities of the Children’s Healthcare of Atlanta Heart Center.
Dr. Maher’s research activities include heart failure in children, pediatric medical device development, Big Data and Analytics, and the application of technology to pediatric research and innovation. He has published more than 75 articles and has presented his research worldwide. Dr. Maher also works on several research collaborations between Children’s and the Georgia Institute of Technology and serves as the medical director of the Pediatric Technology Center at Georgia Tech, where he is an adjunct professor of Biomedical Engineering.
Mr. Storey currently serves as a Portfolio Executive for the National Institutes of Health Rapid Acceleration of Diagnostics (RADx) investment initiative dealing with the US’s SARS-CoV-2 testing crisis. He is also the NIH’s Medical Device Expert for the I-Corps @ NIH™ program and has led international cohorts in the Lean Start-up area in Asia/Pacific, Africa, Europe, Middle East, and South America.
As an Executive in Residence for Johns Hopkins University, he serves on the External Advisory Board for the Johns Hopkins Center for Biomedical Innovation and Design, the Strategic Advisory Board for Johns Hopkins Laboratory for Computational Sensing and Robotics, the JHU Applied Physics Lab Technology Commercialization Panel, the Investment Review Committee for the Bisciotti Fund, and is the Director of the Evaluation Core for the newly awarded Neurotech Harbor initiative (an NIH hub award to Johns Hopkins/Howard University – one of two nationwide).
After earning degrees in chemical engineering and chemistry at the University of Arkansas, Mr. Storey joined Exxon Corporation in Houston, where he worked in performance materials technology, business planning, mergers, and acquisitions for close to 15 years. He was an advisor in Exxon’s Corporate Controller organization, held Sales and Marketing management positions, and crafted the formation of Exxon Chemical’s international joint venture with Mitsubishi Petrochemical. Mr. Storey left Exxon to become General Manager of a privately held engineering company in Maryland. He led the company through a successful sale to Clariant Corporation of Switzerland, where he served as Vice President of Clariant’s Performance Products division.
Following Clariant, Mr. Storey led Vapotherm, Inc. (NYSE: VAPO), a medical device company that specialized in non-invasive respiratory devices, as founding President and CEO. While with the firm for over a dozen years, he received the U.S Commerce Department’s Export Achievement Award, the Maryland World Trade Center International Leadership Award, and Deloitte’s Technology National Fast 500 award four times.
We develop innovations that save lives.
Our purpose drives us to be the world leader for soft tissue healing technologies. Our unique principles drive us to achieve our goals: